Wire · regulatory
Recon: Experts press FDA to set safety, access standards for psychedelic drugs
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 September 2026 · Fusion42 review
Experts are urging the US FDA to establish clear safety and access standards for psychedelic drugs, including credential requirements for providers. This move aims to regulate the emerging psychedelic drug market to ensure patient safety and controlled access.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You face a newly forming regulatory playground in psychedelics where FDA credential rules could redefine who can legally provide these treatments. This sets a gate for market access that you can influence or prepare for now.
◆ Coverage
1 source · 15 Sep 2026
◆ Related on Wire
◆ Topics